SCHEMBL370545

SCHEMBL370545

Cc1sc(Nc2ncccc2I)nc1-c1cn[nH]c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 4/20 0.67
GRM8 O00222 1/20 0.60
KCNH2 Q12809 1/20 0.38
KDR P35968 2/20 0.36
MAOA P21397 2/20 0.35
MAOB P27338 2/20 0.35
ALDH1A1 P00352 3/20 0.35
LMNA P02545 2/20 0.35
POLB P06746 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALOX5 P09917 1/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
GAA P10253 2/20 0.34
MAPT P10636 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL369009 0.86 GRM4 (0.67) GRM4GRM8KCNH2KDRMAOA
SCHEMBL367293 0.84 GRM4 (0.63) GRM4GRM8KCNH2ALDH1A1LMNA
SCHEMBL370278 0.82 GRM4 (0.77) GRM4GRM8KCNH2KDRMAOA
SCHEMBL369152 0.80 GRM4 (1.00) GRM4GRM8KCNH2KDRMAOA
SCHEMBL370275 0.77 GRM4 (0.73) GRM4GRM8KCNH2KDRMAOA
SCHEMBL369060 0.75 GRM4 (1.00) GRM4GRM8KCNH2ALDH1A1LMNA
SCHEMBL370727 0.74 GRM4 (0.73) GRM4GRM8KCNH2KDRPOLB
SCHEMBL15166648 0.74 GRM4 (0.63) GRM4GRM8ALDH1A1ALOX5MEN1
SCHEMBL365873 0.74 GRM4 (0.73) GRM4GRM8KCNH2KDRMAOA
SCHEMBL370185 0.74 GRM4 (0.70) GRM4GRM8KCNH2ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073907-B2 Thiazoles derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors ADDEX PHARMA S.A. (CH) 2015-07-07 US claimed
EP-2376486-B1 NOVEL THIAZOLES DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMACEUTICALS SA (CH) 2013-11-06 EP claimed
US-20110257179-A1 NOVEL THIAZOLES DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA SA (CH) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257179-A1 NOVEL THIAZOLES DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS GRM4, GRM2, GRM1 GRM4 1/4885GRM8 21/4885KCNH2 1489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.